Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125795584 | 12579558 | 4 | F | 20160831 | 20160721 | 20160912 | EXP | GB-CIPLA LTD.-2016GB09864 | CIPLA | 0.00 | Y | 0.00000 | 20160912 | OT | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125795584 | 12579558 | 1 | PS | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Oral | 50 MG, WITHDRAWN BEFORE 13-JUN-2016 | Y | U | 77397 | 50 | MG | ||||||
125795584 | 12579558 | 2 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 75 MG, UNK | U | U | 0 | 75 | MG | ||||||
125795584 | 12579558 | 3 | C | Atorvastatin | ATORVASTATIN | 1 | Oral | 40 MG | U | U | 0 | 40 | MG | ||||||
125795584 | 12579558 | 4 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | 15 MG, AS NECESSARY (PRN BASIS) | U | U | 0 | 15 | MG | ||||||
125795584 | 12579558 | 5 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 20 MG, UNK | U | U | 0 | 20 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125795584 | 12579558 | 1 | Stress |
125795584 | 12579558 | 2 | Prophylaxis |
125795584 | 12579558 | 3 | Prophylaxis |
125795584 | 12579558 | 5 | Hypertension |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125795584 | 12579558 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125795584 | 12579558 | Amnesia | |
125795584 | 12579558 | Anger | |
125795584 | 12579558 | Asthenia | |
125795584 | 12579558 | Decreased appetite | |
125795584 | 12579558 | Diarrhoea | |
125795584 | 12579558 | Disturbance in attention | |
125795584 | 12579558 | Dizziness postural | |
125795584 | 12579558 | Dyskinesia | |
125795584 | 12579558 | Eye pain | |
125795584 | 12579558 | Haemorrhage subcutaneous | |
125795584 | 12579558 | Headache | |
125795584 | 12579558 | Heart rate increased | |
125795584 | 12579558 | Mental disorder | |
125795584 | 12579558 | Nausea | |
125795584 | 12579558 | Palpitations | |
125795584 | 12579558 | Psychiatric symptom | |
125795584 | 12579558 | Somnolence | |
125795584 | 12579558 | Thinking abnormal | |
125795584 | 12579558 | Tinnitus | |
125795584 | 12579558 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125795584 | 12579558 | 1 | 20160602 | 0 | ||
125795584 | 12579558 | 2 | 20141113 | 0 | ||
125795584 | 12579558 | 3 | 20141223 | 0 | ||
125795584 | 12579558 | 4 | 20160125 | 0 | ||
125795584 | 12579558 | 5 | 20150402 | 0 |